Home | Contact Us

 

Looking for something at Eurand.com?

A A A

The page you tried was not found. You may have used an outdated link or may have typed in the address (URL) incorrectly. You might find what you're looking for in these areas:

About Eurand

• Management
• Board of Directors
• Locations
  • Amsterdam
  • Milan
  • Paris
  • Dayton
  • Philadelphia

Products

• Commercialized Products
• In-licensing Strategy
• Products for Out-licensing
  • Diltiazem
  • Nifedipine
  • Temazepam
  • Diphenhydramine HCI
  • EUR 1008
  • Paraffin Oil
  • Vitamin C
  • Cyclobenzaprine ER
  • Ibuprofen
  • Paracetamol
  • Sodium Diclofenac
  • Theophylline

Development Pipeline

• EUR-1008 (U.S.)
• EUR-1008 (Ex-U.S.)
• EUR-1000
• EUR-1025

Pharmaceutical Technologies

• Intellectual Property
• Bioavailability Enhancement
  • Biorise^®
  • Diffucaps^®
• Customized Drug Release
  • Diffucaps^®
  • Diffutab^®
  • Orbexa^®
  • Eurand Minitabs^®
• Taste-Masking and ODTs
  • AdvaTab^®
  • Liquitard^®
  • Microcaps^®
• Case Studies
  • Proprietary Program
  • Mesulid^® Fast
  • AMRIX^®
  • InnoPran XL^®
  • AdvaTab^® Cetirizine HCl
  • Microcaps^® Anti-Infective
• Our Partners
• Manufacturing

News and Publications

• News
• Conferences
• Journal Articles
• Scientific Papers
• Posters

Investor Relations

• Company Overview
• Stock Information
• Financial Information
• Corporate Governance
• News
• Events & Presentations
• Shareholder Meeting
• Investor Contacts
• FAQ

Careers

• Eurand U.S. at a Glance
• Eurand Europe at a Glance
• Career Events
• Employee Testimonials
  • Matt
  • Marco
  • Stefania
  • Anya
  • Nehal
  • Mauro
  • Tara
  • Eleonora

Terms and Conditions

Privacy Policy

Contact Us